強気
$30.22
シナリオ価格
$25.740
+0.252 (+0.98%)終値時点
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
Philips NV (PHG) appears to be a good buy right now due to its strong financial indicators and positive market sentiment. The stock has shown a 5-day change of +6.19%, and its gross margin has improved to 49.31% in Q2 2026, indicating efficient cost management and profitability. However, a key risk is the significant selling pressure from hedge funds, which has increased by 30126.47% over the last quarter, suggesting potential volatility ahead.
Morgan Stanley
—
2026-09-11
Morgan Stanley
2026-09-11
目標株価
—
UBS
—
2026-08-03
UBS
2026-08-03
目標株価
—
Deutsche Bank
—
2026-07-30
Deutsche Bank
2026-07-30
目標株価
—
JPMorgan
—
2026-07-29
JPMorgan
2026-07-29
目標株価
—
Citi
—
2026-07-01
Citi
2026-07-01
目標株価
—
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

EXIT-CVD Project Launched to Enhance Cardiovascular Health

Philips Establishes Global Clinical Advisory Board for Oral Healthcare

Philips Launches Smart Toothbrush to Enhance Oral Care Experience

Philips Launches New CT System to Enhance Emergency Imaging Services

Philips Partners with Red Bull to Showcase Individuality
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others. It operates in the Healthcare sector.
Philips NV (PHG) appears to be a good buy right now due to its strong financial indicators and positive market sentiment. The stock has shown a 5-day change of +6.19%, and its gross margin has improved to 49.31% in Q2 2026, indicating efficient cost management and profitability. However, a key risk is the significant selling pressure from hedge funds, which has increased by 30126.47% over the last quarter, suggesting potential volatility ahead.
1 analysts cover PHG: 1 rate it Buy, 0 Hold and 0 Sell.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。